5. Daklinza
Typical cost for a 30-day supply: $50,700
Treats: hepatitis C
Approved by the Food and Drug Administration last summer, Daklinza can cure 90 percent of patients who haven’t been previously treated and 86 percent of those who had failed a previous treatment. It’s specifically aimed at patients with hep C genotype 3, which is considered the most difficult to treat.
